Exosens Shares Bounce Back 2% Following Military Multi-Sensor Strategy
The French specialist in night vision and imaging technologies for defense rebounds midday after a challenging week. The French specialist in night vision and imaging technologies for defense is up 2.04% at €62.45, in an SBF 120 up by 0.80%, after presenting its multi-sensor strategy.
A 2% Rebound Brings Exosens Back to Its 20-Day Moving Average
Exosens is up 2.04% at €62.45, compared to €61.20 at the previous close. The stock is now in the top half of the SBF 120, which is up by 0.80%.
The day's rebound mitigates the weekly decline, which remains at 6.16%. Over three months, the performance shows a slight decline of 1.81%, while the annual gain holds steady at 39.09%.
The price returns to the proximity of the 20-day moving average (MM20) at €62.36, with only a 0.14% difference, while the 50-day moving average (MM50) at €63.07 is just above the current price. The RSI at 45 remains neutral, with no significant reversal signal.
Multi-Sensor Strategy Unveiled Monday Positions Exosens in the Tactical Vision Segment
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The group detailed its multi-sensor approach for military tactical vision on June 8. The offering combines three complementary imaging technologies: visible low light, short-wave infrared (SWIR), and long-wave infrared (LWIR).
This positioning extends the group's recent industrial sequence, marked by integration into the European SPIRIT project on infrared detection and the announcement of doubling the production capacity of cooled infrared cameras by 2026.
The nearest technical support remains identified at €56.45, while resistance is located at €69.20. Above this, crossing the MM50 at €63.07 is the next observable technical milestone.
Porté par une dynamique commerciale soutenue, en particulier sur les marchés de la Défense et de la Surveillance, ainsi que par une solide exécution opérationnelle
Risks mentioned
Charge de dépréciation de la marque de 28,2 M€ pesant sur le résultat net publié, en baisse de 45,0 %
Incertitudes persistantes sur la recherche scientifique pesant sur la demande en Sciences de la Vie
Contraction de 60 points de base de la marge brute du segment Détection & Imagerie (mix produits)
Opportunities identified
Attribution par l'US Army du contrat IDIQ BiNOD ouvrant le marché américain de la défense
Plan d'expansion de +40 % des capacités de production d'ici 2027, premiers bénéfices au S2 2026
Acquisition d'Emberion, capteurs infrarouges SWIR à points quantiques
Outlook / guidance
Expected revenue: 530 millions d'euros
Expected EBITDA: 173 millions d'euros
Management commentary: chiffre d'affaires compris entre 520 millions d'euros et 540 millions d'euros ; • EBITDA ajusté compris entre 168 millions d'euros et 178 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
